REZVOGLAR KWIKPEN
NDC 50090-6439, Insulin glargine-aglr, injection, solution, from A-S Medication Solutions.
- Product NDC
- 50090-6439
- Status
- Listed
- Labeler
- A-S Medication Solutions
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761215
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50090-6439 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN GLARGINE100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50090-6439-0 | 50090643900 | 5 SYRINGE in 1 CARTON (50090-6439-0) / 3 mL in 1 SYRINGE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/78888c87-7155-4e81-954d-cb40822ee27b
Use it
Look up 50090-6439 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50090-6439 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50090-6439. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.